In support of previous studies, we also observed that BM-MSCs from AML patients expressed similar cell-surface markers and adhesion proteins compared to BM-MSCs from healthy donors, such as β1 integrin, CD44, CD73, CD90, and E-cadherin. This evidence concerns the gene THY1 and acute myeloid leukemia.